![]() |
Volumn 12, Issue 2, 2007, Pages 142-143
|
Guillain-Barré syndrome after combined CHOP and rituximab therapy in non-Hodgkin lymphoma [2]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
IMMUNOGLOBULIN;
METHYLPREDNISOLONE;
RITUXIMAB;
VINCRISTINE;
B CELL LYMPHOMA;
CLINICAL FEATURE;
DIAGNOSTIC APPROACH ROUTE;
DIAGNOSTIC TEST;
DISEASE COURSE;
DRUG MEGADOSE;
GENERAL CONDITION IMPROVEMENT;
GUILLAIN BARRE SYNDROME;
HUMAN;
LETTER;
MEDICAL EXAMINATION;
MULTIPLE CYCLE TREATMENT;
NONHODGKIN LYMPHOMA;
PRIORITY JOURNAL;
THERAPY EFFECT;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
ADULT;
ANTI-INFLAMMATORY AGENTS;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
GUILLAIN-BARRE SYNDROME;
HUMANS;
IMMUNOGLOBULINS, INTRAVENOUS;
LYMPHOMA, NON-HODGKIN;
MALE;
METHYLPREDNISOLONE;
PLASMA EXCHANGE;
PREDNISONE;
VINCRISTINE;
|
EID: 34250186096
PISSN: 10859489
EISSN: 15298027
Source Type: Journal
DOI: 10.1111/j.1529-8027.2007.00134.x Document Type: Letter |
Times cited : (21)
|
References (9)
|